ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 25 filers reported holding ARCA BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $1,244,197 | +3.5% | 706,930 | 0.0% | 0.82% | -9.9% |
Q4 2023 | $1,201,781 | -15.4% | 706,930 | 0.0% | 0.91% | -30.3% |
Q3 2023 | $1,420,929 | -1.0% | 706,930 | 0.0% | 1.30% | +1.1% |
Q2 2023 | $1,435,068 | +2.0% | 706,930 | 0.0% | 1.29% | +6.2% |
Q1 2023 | $1,406,791 | -30.8% | 706,930 | -17.6% | 1.22% | -37.4% |
Q4 2022 | $2,034,067 | – | 858,256 | – | 1.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newtyn Management, LLC | 500,000 | $1,030,000 | 0.23% |
SG3 Management, LLC | 200,000 | $412,000 | 0.03% |
Marquette Asset Management, LLC | 17,318 | $36,000 | 0.01% |
SG3 Management, LLC | 75,412 | $155,674 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,948 | $97,000 | 0.00% |
Tekla Capital Management LLC | 32,461 | $67,000 | 0.00% |
Virtu Financial LLC | 14,221 | $29,000 | 0.00% |
GROUP ONE TRADING, L.P. | 144,284 | $297,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 96 | $0 | 0.00% |
NORTHERN TRUST CORP | 17,517 | $36,000 | 0.00% |